IOVA logo

IOVANCE BIOTHERAPEUTICS INC

IOVANASDAQ
🏆 #1452 by market capEarnings Nov 4US Equity
$647.19▲ $28.02 (+4.33%)
Simulated price
1h—
24h▲ 4.3%
7d—
14d—
30d—
1y—
🏦Market Cap
$2.90B
Small Cap
📈Revenue Growth (YoY)
+60.6%
High Growth
📊Gross Margin
116.3%
High
💵FCF Margin
-91.2%
Thin
⚖️P/S Ratio
8.9x
Elevated
Otter Score
60
Fair
📊

Analyst Ratings

Price
$647.19
Total
20
Raised
1
Lowered
2
Avg PT
$7.25
H / L
$13 / $5
InstitutionActionRatingDate
Chardan Capital
ReiteratedBuy2026-05-07
UBS
ReiteratedNeutral2026-03-05
Citizens
UpgradedMarket Perform → Market Outperform2026-03-03
Barclays
ReiteratedOverweight2026-02-25
HC Wainwright & Co.
ReiteratedBuy2025-10-29
Wells Fargo
ReiteratedOverweight2025-08-08
Goldman Sachs
ReiteratedBuy2025-05-12
Mizuho
ReiteratedOutperform2025-05-12
JMP Securities
DowngradedMarket Outperform → Market Perform2025-05-09
Truist Securities
ReiteratedBuy2025-03-03
Baird
ReiteratedOutperform2025-02-28
Piper Sandler
ReiteratedNeutral2025-02-28
Stifel
ReiteratedBuy2023-09-15
Oppenheimer
ReiteratedOutperform2023-03-01
Benchmark
DowngradedBuy → Neutral2022-12-09
Guggenheim
ReiteratedNeutral2022-10-31
PiperJaffray
ReiteratedOverweight2019-04-29
H.C. Wainwright
ReiteratedBuy2018-10-12
B. Riley FBR
ReiteratedBuy2018-05-11
B. Riley Securities
ReiteratedBuy2018-05-11
One row per institution, most recent rating